Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Treasury Shares (2021 - 2026)

Exagen filings provide 6 years of Treasury Shares readings, the most recent being $2.1 million for Q1 2026.

  • On a quarterly basis, Treasury Shares rose 16.85% to $2.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.1 million, a 16.85% increase, with the full-year FY2025 number at $1.8 million, up 4.99% from a year prior.
  • Treasury Shares hit $2.1 million in Q1 2026 for Exagen, up from $1.8 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $2.1 million in Q1 2026 to a low of $784940.0 in Q2 2022.
  • Median Treasury Shares over the past 5 years was $1.7 million (2024), compared with a mean of $1.5 million.
  • Biggest five-year swings in Treasury Shares: surged 374.91% in 2022 and later decreased 2.52% in 2025.
  • Exagen's Treasury Shares stood at $1.0 million in 2022, then soared by 33.9% to $1.4 million in 2023, then grew by 23.27% to $1.7 million in 2024, then grew by 4.99% to $1.8 million in 2025, then grew by 18.6% to $2.1 million in 2026.
  • The last three reported values for Treasury Shares were $2.1 million (Q1 2026), $1.8 million (Q4 2025), and $1.8 million (Q3 2025) per Business Quant data.